Skip to main content
    S

    SkinHealth Systems Inc. (SKIN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $15.05
    -1.26 (-7.73%)

    Market Cap: $106.26M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    SkinHealth Systems Inc. (SKIN) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    SkinHealth Systems (SKIN) trades at 0.3x sales and 1.8x book value. Its forward P/E is 106.4x.

    Current Multiples

    Its enterprise value is 7.2x its EBITDA. Its free cash flow yield is 23.2%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E106.4x
    Price to sales0.3x
    Price to book1.8x
    EV/EBITDA7.2x
    Price to FCF4.3x
    EV/FCF10.1x
    PEGN/A
    FCF yield23.2%
    As of Nov 17, 2026

    Valuation History

    Over the 3 of the 6 year ends shown that have a P/E, its P/E ranged from 353.3x in 2024 to 695.0x in 2025.

    Year endPriceP/EP/B
    2025$27.80695.0x58.0x
    2024$31.80353.3x76.4x
    2023$62.20365.9xN/A
    2022$182.00N/A150.6x
    2021$483.20N/AN/A
    2020$226.20N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SKIN

    What is SKIN's forward P/E ratio?

    SkinHealth Systems has a forward P/E ratio of 106.4x.

    Is SKIN stock overvalued?

    GNG's valuation label for SKIN is Undervalued.

    What is SKIN's price to sales ratio?

    SkinHealth Systems has a price to sales ratio of 0.3x.